Could diabetes drugs be the key to halting heart disease?
NCT ID NCT07254572
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 19 times
Summary
This study compares two diabetes medications, semaglutide and dapagliflozin, against standard treatment (metformin) to see if they can slow or reverse the buildup of plaque in the heart arteries. The trial involves 300 adults with pre-diabetes and confirmed coronary artery disease, and will track changes over 24 months using CT scans. The goal is to find a better way to manage heart disease risk in this high-risk group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Cardiology, Department of Coronary Artery and Structural Heart Diseases
RECRUITINGWarsaw, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.